Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)

HIV-associated neurocognitive disorders (HAND) continues to be prevalent (30–50 %) despite plasma HIVRNA suppression with combination antiretroviral therapy (cART). There is no proven therapy for individuals on suppressive cARTwith HAND. We have shown that the degree of HIV reservoir burden (HIV DNA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurovirol
Autors principals: Ndhlovu, Lishomwa C., Umaki, Tracie, Chew, Glen M., Chow, Dominic C., Agsalda, Melissa, Kallianpur, Kalpana J., Paul, Robert, Zhang, Guangxiang, Ho, Erika, Hanks, Nancy, Nakamoto, Beau, Shiramizu, Bruce T., Shikuma, Cecilia M.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268390/
https://ncbi.nlm.nih.gov/pubmed/25227930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13365-014-0279-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars